Tempus AI Inc

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tempus AI Inc reports strong Q3 results and strategic acquisitions

Tempus AI Inc (TEM) showcased robust performance in Q3 2024, driven by revenue growth and strategic acquisitions, positioning the company for continued success.
While challenges like organizational readiness and market dynamics exist, the company's disciplined approach and strong partnerships present opportunities for sustained growth.
Overall, Tempus' focus on innovation, customer-centricity, and financial discipline sets a solid foundation for future growth and market leadership in the healthcare technology sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

One of the season's most highly anticipated initial public offerings (IPOs) is taking place today. Tempus AI (NASDAQ: TEM ), a company bringing artificial intelligence (AI) to the data processing space, begins trading today after weeks of anticipation.

TEM Stock IPO: 7 Things to Know as Tempus AI Starts Trading Today

SoftBank Group-backed Tempus AI announced on Thursday the pricing of its initial public offering of 11.1 million ordinary shares at a price of $37 apiece.

Tempus AI announces pricing of US IPO

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (“Tempus”) today announced the pricing of its initial public offering of 11,100,000 shares of its Class A common stock at a public offering price of $37.00 per share. All of the shares of Class A common stock are being offered by Tempus. The gross proceeds to Tempus from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Tempus, are expected to be $410.7 million. In addition, Tempus has granted t.

Tempus Announces Pricing of Initial Public Offering

Tempus AI stock is preparing for an initial public offering ( IPO ) and we have all of the details that traders need to know about before it gets here. Let's get into all of the latest Tempus AI IPO details below ahead of its potential listing this week!

TEM Stock IPO: When Does Tempus AI Go Public? What Is the Tempus AI IPO Price Range?

Tempus AI Inc. is about to give investors a way to play the intersection of medicine and artificial intelligence.

Healthcare-technology company Tempus AI looks to raise $400 million in IPO

Tempus AI is targeting a valuation of up to $6.10 billion in its initial public offering in the United States, the genetics testing company said on Wednesday.

Tempus AI seeks up to $6.1 bln valuation in US IPO

Eric Lefkofsky knows the public listing rodeo well and is about to enter it for a fourth time. The serial entrepreneur, whose net worth is estimated at nearly $4 billion, has already taken three businesses he's founded public.

Billionaire Groupon founder Lefkofsky is back with another IPO: AI healthtech Tempus

Centurion Acquisition Corp

Bowhead Specialty Holdings Inc

Waystar Holding Corp

Specialty property & casualty insurer Bowhead Specialty Holdings priced its upsized IPO at the top of the range to raise $128 million at a $551 million market cap. Three IPOs submitted initial filings this past week. The May IPO market is expected to end on a quiet note, with no IPOs currently scheduled for the short Memorial Day week.

U.S. IPO Weekly Recap: Specialty Insurer Bowhead Sole IPO To Debut As More Names Join The Pipeline

Tempus AI, Inc. has filed for a $100 million IPO of its Class A common stock. The company uses healthcare data and analytics to improve decision-making in the medical field. While Tempus is experiencing revenue growth, it is also facing heavy operating losses and cash burn.

Tempus AI's High Stakes IPO: A Gamble On Growth Amid Soaring Losses

News for Tempus AI Inc Stock (TEM)